Bladder cancer: open trials in Austria

12 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Medizinische Universitaet Graz, Graz · Medizinische Universität Innsbruck, Innsbruck · Medical University Vienna MUV, Leopoldsdorf (Wien) · Ordensklinikum Linz GmbH Elisabethinen, Linz · Universitaetsklinikum Salzburg Landeskrankenhaus, Salzburg
Registry updated 2026-11-03
2024-516906-47-00
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Trial Treatment · Phase 2/3 · Daiichi Sankyo Inc.
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Universitaetsklinikum Krems, Krems An Der Donau · Ordensklinikum Linz GmbH, Linz · SCRI CCCIT Ges.m.b.H., Salzburg · Krankenhaus Der Barmherzigen Brueder Wien, Vienna · Medical University of Vienna, Vienna · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-10-29
NCT07222488
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Medical University of Vienna, Vienna
Registry updated 2026-10-29
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
University Hospital Graz, Graz · Krankenhaus Der Barmherzigen Brueder Wien, Vienna · Medical University of Vienna, Vienna
Registry updated 2026-10-01
NCT07129993
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Trial Treatment · Phase 2/3 · Daiichi Sankyo
Graz · Krems · Linz · Salzburg · Vienna
Registry updated 2026-08-20
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Medizinische Universitaet Innsbruck, Innsbruck · Klinik Ottakring, Vienna · Medizinische Universität Wien, Vienna
Registry updated 2026-07-29
NCT07034053
Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma
Trial Treatment · Phase 1/2 · Ekaterina Laukhtina
Department of Urology, Medical University of Vienna, Vienna
Registry updated 2025-06-26
NCT07019220
Chemoablation for Low-Grade Bladder Cancer
Trial Treatment · Phase 2 · Ekaterina Laukhtina
Department of Urology, Medical University of Vienna, Vienna
Registry updated 2025-06-13
2024-517106-28-00
COBRA - Chemoablation for Low Grade Bladder Cancer: A single arm, prospective, open-label, investigator-initiated Phase 2 study
Trial Treatment · Phase 2 · Medical University Of Vienna
Medical University of Vienna, Vienna
Registry updated 2024-10-30
2024-516586-37-00
Clofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study
Trial Treatment · Phase 1/2 · Medical University Of Vienna
Medical University of Vienna, Vienna
Registry updated 2024-10-14
NCT05810623
Single-Dose Intravesical Chemotherapy After Diagnostic URS
Trial Treatment · Phase 3 · David D'Andrea
Medical University of Vienna, Vienna
Registry updated 2023-04-12
NCT05792033
Multicentric Prospective T1 Urinary Bladder Cancer Registry
Research · Medical University of Vienna
Medical University of Vienna, Vienna
Registry updated 2023-04-04

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error